Global and United States Pneumonia Vaccine Market Report & Forecast 2022-2028

Global and United States Pneumonia Vaccine Market Report & Forecast 2022-2028

Table of Contents
1 Study Coverage
1.1 Pneumonia Vaccine Product Introduction
1.2 Global Pneumonia Vaccine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Pneumonia Vaccine Sales in US$ Million for the Year 2017-2028
1.2.2 Global Pneumonia Vaccine Sales in Volume for the Year 2017-2028
1.3 United States Pneumonia Vaccine Outlook 2017 VS 2022 VS 2028
1.3.1 United States Pneumonia Vaccine Sales in US$ Million for the Year 2017-2028
1.3.2 United States Pneumonia Vaccine Sales in Volume for the Year 2017-2028
1.4 Pneumonia Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Pneumonia Vaccine in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Pneumonia Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Pneumonia Vaccine Market Dynamics
1.5.1 Pneumonia Vaccine Industry Trends
1.5.2 Pneumonia Vaccine Market Drivers
1.5.3 Pneumonia Vaccine Market Challenges
1.5.4 Pneumonia Vaccine Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Pneumonia Vaccine Market Segment by Type
2.1.1 Pneumococcal Conjugate Vaccine (PCV13)
2.1.2 Pneumococcal Polysaccharide Vaccine (PPSV23)
2.1.3 Other
2.2 Global Pneumonia Vaccine Market Size by Type
2.2.1 Global Pneumonia Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Pneumonia Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Pneumonia Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Pneumonia Vaccine Market Size by Type
2.3.1 United States Pneumonia Vaccine Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Pneumonia Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Pneumonia Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Pneumonia Vaccine Market Segment by Application
3.1.1 Pneumonia
3.1.2 Meningitis
3.1.3 Sepsis
3.2 Global Pneumonia Vaccine Market Size by Application
3.2.1 Global Pneumonia Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Pneumonia Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Pneumonia Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Pneumonia Vaccine Market Size by Application
3.3.1 United States Pneumonia Vaccine Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Pneumonia Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Pneumonia Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Pneumonia Vaccine Competitor Landscape by Company
4.1 Global Pneumonia Vaccine Market Size by Company
4.1.1 Top Global Pneumonia Vaccine Manufacturers Ranked by Revenue (2021)
4.1.2 Global Pneumonia Vaccine Revenue by Manufacturer (2017-2022)
4.1.3 Global Pneumonia Vaccine Sales by Manufacturer (2017-2022)
4.1.4 Global Pneumonia Vaccine Price by Manufacturer (2017-2022)
4.2 Global Pneumonia Vaccine Concentration Ratio (CR)
4.2.1 Pneumonia Vaccine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Pneumonia Vaccine in 2021
4.2.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Pneumonia Vaccine Manufacturing Base Distribution, Product Type
4.3.1 Global Pneumonia Vaccine Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Pneumonia Vaccine Product Type
4.3.3 Date of International Manufacturers Enter into Pneumonia Vaccine Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Pneumonia Vaccine Market Size by Company
4.5.1 Top Pneumonia Vaccine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Pneumonia Vaccine Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Pneumonia Vaccine Sales by Players (2020, 2021 & 2022)
5 Global Pneumonia Vaccine Market Size by Region
5.1 Global Pneumonia Vaccine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Pneumonia Vaccine Market Size in Volume by Region (2017-2028)
5.2.1 Global Pneumonia Vaccine Sales in Volume by Region: 2017-2022
5.2.2 Global Pneumonia Vaccine Sales in Volume Forecast by Region (2023-2028)
5.3 Global Pneumonia Vaccine Market Size in Value by Region (2017-2028)
5.3.1 Global Pneumonia Vaccine Sales in Value by Region: 2017-2022
5.3.2 Global Pneumonia Vaccine Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Pneumonia Vaccine Market Size YoY Growth 2017-2028
6.1.2 North America Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Pneumonia Vaccine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Pneumonia Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Pneumonia Vaccine Market Size YoY Growth 2017-2028
6.3.2 Europe Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Pneumonia Vaccine Market Size YoY Growth 2017-2028
6.4.2 Latin America Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Pneumonia Vaccine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Pfizer Inc.
7.1.1 Pfizer Inc. Corporation Information
7.1.2 Pfizer Inc. Description and Business Overview
7.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Pfizer Inc. Pneumonia Vaccine Products Offered
7.1.5 Pfizer Inc. Recent Development
7.2 Glaxosmithkline Plc.
7.2.1 Glaxosmithkline Plc. Corporation Information
7.2.2 Glaxosmithkline Plc. Description and Business Overview
7.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Products Offered
7.2.5 Glaxosmithkline Plc. Recent Development
7.3 Merck & Co., Inc.
7.3.1 Merck & Co., Inc. Corporation Information
7.3.2 Merck & Co., Inc. Description and Business Overview
7.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck & Co., Inc. Pneumonia Vaccine Products Offered
7.3.5 Merck & Co., Inc. Recent Development
7.4 Sanofi Pasteur
7.4.1 Sanofi Pasteur Corporation Information
7.4.2 Sanofi Pasteur Description and Business Overview
7.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Sanofi Pasteur Pneumonia Vaccine Products Offered
7.4.5 Sanofi Pasteur Recent Development
7.5 Serum Institute of India Pvt. Ltd.
7.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
7.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
7.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Products Offered
7.5.5 Serum Institute of India Pvt. Ltd. Recent Development
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Corporation Information
7.6.2 Johnson & Johnson Description and Business Overview
7.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Johnson & Johnson Pneumonia Vaccine Products Offered
7.6.5 Johnson & Johnson Recent Development
7.7 Astellas Pharma Inc.
7.7.1 Astellas Pharma Inc. Corporation Information
7.7.2 Astellas Pharma Inc. Description and Business Overview
7.7.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Astellas Pharma Inc. Pneumonia Vaccine Products Offered
7.7.5 Astellas Pharma Inc. Recent Development
7.8 Astrazeneca Plc.
7.8.1 Astrazeneca Plc. Corporation Information
7.8.2 Astrazeneca Plc. Description and Business Overview
7.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Astrazeneca Plc. Pneumonia Vaccine Products Offered
7.8.5 Astrazeneca Plc. Recent Development
7.9 CSL Limited
7.9.1 CSL Limited Corporation Information
7.9.2 CSL Limited Description and Business Overview
7.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.9.4 CSL Limited Pneumonia Vaccine Products Offered
7.9.5 CSL Limited Recent Development
7.10 Emergent Biosolutions
7.10.1 Emergent Biosolutions Corporation Information
7.10.2 Emergent Biosolutions Description and Business Overview
7.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Emergent Biosolutions Pneumonia Vaccine Products Offered
7.10.5 Emergent Biosolutions Recent Development
7.11 Walvax Biotechnology
7.11.1 Walvax Biotechnology Corporation Information
7.11.2 Walvax Biotechnology Description and Business Overview
7.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.11.4 Walvax Biotechnology Pneumonia Vaccine Products Offered
7.11.5 Walvax Biotechnology Recent Development
7.12 Royal (Wuxi) Bio-Pharmaceutical
7.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
7.12.2 Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
7.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.12.4 Royal (Wuxi) Bio-Pharmaceutical Products Offered
7.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Development
7.13 Zhifei Biologic
7.13.1 Zhifei Biologic Corporation Information
7.13.2 Zhifei Biologic Description and Business Overview
7.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Zhifei Biologic Products Offered
7.13.5 Zhifei Biologic Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Pneumonia Vaccine Industry Chain Analysis
8.2 Pneumonia Vaccine Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Pneumonia Vaccine Distributors
8.3 Pneumonia Vaccine Production Mode & Process
8.4 Pneumonia Vaccine Sales and Marketing
8.4.1 Pneumonia Vaccine Sales Channels
8.4.2 Pneumonia Vaccine Distributors
8.5 Pneumonia Vaccine Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Pneumonia Vaccine CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Pneumonia Vaccine Market Trends
Table 3. Pneumonia Vaccine Market Drivers
Table 4. Pneumonia Vaccine Market Challenges
Table 5. Pneumonia Vaccine Market Restraints
Table 6. Global Pneumonia Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Pneumonia Vaccine Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Pneumonia Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Pneumonia Vaccine Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Pneumonia Vaccine Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Pneumonia Vaccine Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Pneumonia Vaccine Revenue Share by Manufacturer, 2017-2022
Table 13. Global Pneumonia Vaccine Sales by Manufacturer, (K Doses), 2017-2022
Table 14. Global Pneumonia Vaccine Sales Share by Manufacturer, 2017-2022
Table 15. Global Pneumonia Vaccine Price by Manufacturer (2017-2022) & (USD/Dose)
Table 16. Global Pneumonia Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Pneumonia Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pneumonia Vaccine as of 2021)
Table 18. Top Players of Pneumonia Vaccine in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Pneumonia Vaccine Product Type
Table 20. Date of International Manufacturers Enter into Pneumonia Vaccine Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Pneumonia Vaccine Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Pneumonia Vaccine Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Pneumonia Vaccine Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Pneumonia Vaccine Sales by Players, (K Doses), 2020, 2021 & 2022
Table 26. United States Pneumonia Vaccine Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Pneumonia Vaccine Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Pneumonia Vaccine Sales in Volume by Region (2017-2022) & (K Doses)
Table 29. Global Pneumonia Vaccine Sales in Volume Forecast by Region (2023-2028) & (K Doses)
Table 30. Global Pneumonia Vaccine Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Pneumonia Vaccine Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 33. North America Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Pneumonia Vaccine Sales in Volume by Region (2017-2028) & (K Doses)
Table 35. Asia Pacific Pneumonia Vaccine Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 37. Europe Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 39. Latin Americaa Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Pneumonia Vaccine Sales in Volume by Country (2017-2028) & (K Doses)
Table 41. Middle East and Africa Pneumonia Vaccine Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Pfizer Inc. Corporation Information
Table 43. Pfizer Inc. Description and Business Overview
Table 44. Pfizer Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 45. Pfizer Inc. Pneumonia Vaccine Product
Table 46. Pfizer Inc. Recent Development
Table 47. Glaxosmithkline Plc. Corporation Information
Table 48. Glaxosmithkline Plc. Description and Business Overview
Table 49. Glaxosmithkline Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 50. Glaxosmithkline Plc. Product
Table 51. Glaxosmithkline Plc. Recent Development
Table 52. Merck & Co., Inc. Corporation Information
Table 53. Merck & Co., Inc. Description and Business Overview
Table 54. Merck & Co., Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 55. Merck & Co., Inc. Product
Table 56. Merck & Co., Inc. Recent Development
Table 57. Sanofi Pasteur Corporation Information
Table 58. Sanofi Pasteur Description and Business Overview
Table 59. Sanofi Pasteur Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 60. Sanofi Pasteur Product
Table 61. Sanofi Pasteur Recent Development
Table 62. Serum Institute of India Pvt. Ltd. Corporation Information
Table 63. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 64. Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 65. Serum Institute of India Pvt. Ltd. Product
Table 66. Serum Institute of India Pvt. Ltd. Recent Development
Table 67. Johnson & Johnson Corporation Information
Table 68. Johnson & Johnson Description and Business Overview
Table 69. Johnson & Johnson Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 70. Johnson & Johnson Product
Table 71. Johnson & Johnson Recent Development
Table 72. Astellas Pharma Inc. Corporation Information
Table 73. Astellas Pharma Inc. Description and Business Overview
Table 74. Astellas Pharma Inc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 75. Astellas Pharma Inc. Product
Table 76. Astellas Pharma Inc. Recent Development
Table 77. Astrazeneca Plc. Corporation Information
Table 78. Astrazeneca Plc. Description and Business Overview
Table 79. Astrazeneca Plc. Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 80. Astrazeneca Plc. Product
Table 81. Astrazeneca Plc. Recent Development
Table 82. CSL Limited Corporation Information
Table 83. CSL Limited Description and Business Overview
Table 84. CSL Limited Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 85. CSL Limited Product
Table 86. CSL Limited Recent Development
Table 87. Emergent Biosolutions Corporation Information
Table 88. Emergent Biosolutions Description and Business Overview
Table 89. Emergent Biosolutions Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 90. Emergent Biosolutions Product
Table 91. Emergent Biosolutions Recent Development
Table 92. Walvax Biotechnology Corporation Information
Table 93. Walvax Biotechnology Description and Business Overview
Table 94. Walvax Biotechnology Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 95. Walvax Biotechnology Product
Table 96. Walvax Biotechnology Recent Development
Table 97. Royal (Wuxi) Bio-Pharmaceutical Corporation Information
Table 98. Royal (Wuxi) Bio-Pharmaceutical Description and Business Overview
Table 99. Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 100. Royal (Wuxi) Bio-Pharmaceutical Product
Table 101. Royal (Wuxi) Bio-Pharmaceutical Recent Development
Table 102. Zhifei Biologic Corporation Information
Table 103. Zhifei Biologic Description and Business Overview
Table 104. Zhifei Biologic Pneumonia Vaccine Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 105. Zhifei Biologic Product
Table 106. Zhifei Biologic Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Pneumonia Vaccine Customers List
Table 110. Pneumonia Vaccine Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Pneumonia Vaccine Product Picture
Figure 2. Global Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Pneumonia Vaccine Market Size 2017-2028 (US$ Million)
Figure 4. Global Pneumonia Vaccine Sales 2017-2028 (K Doses)
Figure 5. United States Pneumonia Vaccine Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Pneumonia Vaccine Market Size 2017-2028 (US$ Million)
Figure 7. United States Pneumonia Vaccine Sales 2017-2028 (K Doses)
Figure 8. United States Pneumonia Vaccine Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Pneumonia Vaccine Market Share in Global, in Volume (K Doses) 2017-2028
Figure 10. Pneumonia Vaccine Report Years Considered
Figure 11. Product Picture of Pneumococcal Conjugate Vaccine (PCV13)
Figure 12. Product Picture of Pneumococcal Polysaccharide Vaccine (PPSV23)
Figure 13. Product Picture of Other
Figure 14. Global Pneumonia Vaccine Market Share by Type in 2022 & 2028
Figure 15. Global Pneumonia Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 16. Global Pneumonia Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 17. Global Pneumonia Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 18. Global Pneumonia Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 19. Global Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 20. United States Pneumonia Vaccine Market Share by Type in 2022 & 2028
Figure 21. United States Pneumonia Vaccine Sales in Value by Type (2017-2028) & (US$ Million)
Figure 22. United States Pneumonia Vaccine Sales Market Share in Value by Type (2017-2028)
Figure 23. United States Pneumonia Vaccine Sales by Type (2017-2028) & (K Doses)
Figure 24. United States Pneumonia Vaccine Sales Market Share in Volume by Type (2017-2028)
Figure 25. United States Pneumonia Vaccine Price by Type (2017-2028) & (USD/Dose)
Figure 26. Product Picture of Pneumonia
Figure 27. Product Picture of Meningitis
Figure 28. Product Picture of Sepsis
Figure 29. Global Pneumonia Vaccine Market Share by Application in 2022 & 2028
Figure 30. Global Pneumonia Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Pneumonia Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Pneumonia Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 33. Global Pneumonia Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 35. United States Pneumonia Vaccine Market Share by Application in 2022 & 2028
Figure 36. United States Pneumonia Vaccine Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Pneumonia Vaccine Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Pneumonia Vaccine Sales by Application (2017-2028) & (K Doses)
Figure 39. United States Pneumonia Vaccine Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Pneumonia Vaccine Price by Application (2017-2028) & (USD/Dose)
Figure 41. North America Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 42. North America Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 46. Europe Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 53. Asia-Pacific Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 65. Latin America Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Pneumonia Vaccine Sales in Volume Growth Rate 2017-2028 (K Doses)
Figure 70. Middle East & Africa Pneumonia Vaccine Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. U.A.E Pneumonia Vaccine Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Pneumonia Vaccine Value Chain
Figure 75. Pneumonia Vaccine Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs